Factor XI and XII as antithrombotic targets

Arterial and venous thrombosis are major causes of morbidity and mortality, and the incidence of thromboembolic diseases increases as a population ages. Thrombi are formed by activated platelets and fibrin. The latter is a product of the plasma coagulation system. Currently available anticoagulants...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current opinion in hematology Jg. 18; H. 5; S. 349
Hauptverfasser:	Müller, Felicitas, Gailani, David, Renné, Thomas
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.09.2011
Schlagworte:	Animals Anticoagulants - pharmacology Anticoagulants - therapeutic use Blood Coagulation - drug effects Blood Coagulation - physiology Factor XI - antagonists & inhibitors Factor XI - metabolism Factor XI Deficiency - blood Factor XI Deficiency - drug therapy Factor XI Deficiency - metabolism Factor XII - antagonists & inhibitors Factor XII - metabolism Factor XII Deficiency - blood Factor XII Deficiency - drug therapy Factor XII Deficiency - metabolism Hemostasis - drug effects Hemostasis - physiology Humans Thrombosis - drug therapy Thrombosis - metabolism
ISSN:	1531-7048, 1531-7048
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!